Tuesday, February 27, 2018 12:25:44 PM
Shares (1) Price
Per Share (1) Warrants (1) Warrant
Exercise
Price Per Share (1)
Total
Capital
Raised
$0.05 Financing (2) 4,000,000 $0.05 2,000,000 $0.25 $ 200,000
$0.10 Financing (3) 6,175,000 $0.10 3,237,500 $0.25 $ 617,500
$1.25 Financing (4) 2,841,300 $1.25 – - $ 3,551,625
13,016,300 5,237,500 $ 4,369,125
(1) Share and warrant quantities and their respective per-share prices have been retroactively adjusted for the forward 2-for-1 split on January 16, 2018.
(2) The $0.05 Financing commenced on November 15, 2017, pursuant to which the Company raised $200,000 from 2 accredited investors. As part of the investment in $0.05 Financing, we issued and sold 2,000,000 units, each consisting of two (2) shares of common stock and one (1) warrant exercisable for 3 years at an exercise price of $0.25.
(3) The $0.10 Financing commenced on November 21, 2017, pursuant to which the Company raised $617,500 from 54 accredited investors. As part of the investment in $0.10 Financing, we issued and sold 3,087,500 units, each consisting of two (2) shares of common stock and one (1) warrant exercisable for 3 years at an exercise price of $0.25.
(4) The $1.25 Financing commenced on November 30, 2017. The Company expects to close this round by February 28, 2018. The Company has raised $3,551,625 from 124 accredited investors. As part of the investment in $1.25 Financing, we issued and sold 2,841,300 shares of common stock. No warrants were issued with this round.
The Company intends to continue to seek to raise additional equity capital through private placement of shares and/or units consisting of shares and warrants to accredited investors.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM